Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NTRB is expected to report earnings to fall 93.12% to -12 cents per share on July 01
Q2'26
Est.
$-0.13
Q1'26
Est.
$-1.89
Q4'25
Beat
by $1.81
Q3'25
Missed
by $1.95
Q1'25
Missed
by $0.38
The last earnings report on May 01 showed earnings per share of -188 cents, meeting the estimate of -188 cents. With 7.31K shares outstanding, the current market capitalization sits at 37.81M.